Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation

Xenotransplantation

Volumn 10, Issue 6, 2003, Pages 587-595

  Cozzi, Emanuele ^a,e   Cadrobbi, Roberto ^a   Baldan, Nicola ^a   Dedja, Arben ^a   Calabrese, Fiorella ^a   Castagnaro, Massimo ^b   Fante, Fabio ^a   Boldrin, Massimo ^a   Iacopetti, Ilaria ^a   Ravarotto, Licia ^c   Carraro, Paolo ^d   Bronte, Vincenzo ^d   De Santo, Carmela ^d   Busetto, Roberto ^a   Plebani, Mario ^d   Cancellotti, Francesco Maria ^c   Rigotti, Paolo ^a   Thiene, Gaetano ^a   Ancona, Ermanno ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Public Health   (Italy)

^c Institute for Animal Health Prophylaxis   (Italy)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^e Clinica Chirurgica II   (Italy)

Author keywords

DAF; Decay accelerating factor; Immunosuppression; Kidney; Methotrexate; Pig; Primate; Transgenic; Xenotransplantation

Indexed keywords

CYCLOSPORIN A; DELTACORTENE; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; PREDNISONE; STEROID; DECAY ACCELERATING FACTOR; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENTERITIS; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LONG TERM CARE; LYMPHOCYTE; MALE; MONKEY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SWINE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETICS; GRAFT REJECTION; HUMAN; MACACA; METABOLISM; PATHOLOGY; SMALL INTESTINE; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; DIARRHEA; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; METHOTREXATE; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0142152980     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.00060.x     Document Type: Article

References (34)

1. COZZI E, BHATTI F, SCHMOECKEL M et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15.
2. VIAL CM, OSTLIE DJ, BHATTI FN. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19: 224.
3. BHATTI FN, SCHMOECKEL M, ZAIDI A et al. Three-month survival of HDAF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 31: 958.
4. HASAN RIR, VAN DEN BOGARDE J, FORTY J et al. Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc 1992; 24: 517.
5. GENESTIER L, PAILLOT R, QUEMENEUR L, IZERADJENE K, REVILLARD JP. Mechanisms of action of methotrexate. Immunopharmacology 2000; 47: 247.
6. ROSENTHAL GJ, WEIGAND GW, GERMOLEC DR, BLANK JA, LUSTER MI. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. J Immunol 1988; 41: 410.
7. JOHNSON WJ, DIMARTINO MJ, MEUNIER PC, MUIRHEAD KA, HANNA N. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol 1988; 15: 745.
8. SEGAL R, MOZES E, YARON M, TARTAKOVSKY B. The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989; 32: 370.
9. HASAN RI, SRIWATANAWONGSA V, WALLWORK J, WHITE DJ. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species anti-bodies with methotrexate. Transplant Proc 1993; 25: 421.
10. HASAN RI, SRIWATANAWANGOSA V, WALLWORK J, WHITE DJ. Graft adaptation in hamster-to-rat cardiac xenografts. Transplant Proc 1994; 26: 1282.
11. KAWAUCHI M, GUNDRY SR, DE BEGONA JA et al. Prolonged survival of orthotopically transplanted heart xenograft in infant baboons. J Thorac Cardiovasc Surg 1993; 106: 779.
12. BAILEY LL, GUNDRY SR. Survival following orthotopic cardiac xenotransplantation between juvenile baboon recipients and concordant and discordant donor species: foundation for clinical trials. World J Surg 1997; 21: 943.
13. TERANISHI K, TRETER S, ALWAYN IP et al. Assessment of methotrexate as a potential immunosuppressive agent in baboons. J Heart Lung Transplant 2001; 20: 1335.
14. COZZI E, WHITE DJG. The generation of transgenic pigs as potential organ donors for humans. Nature Med 1995; 1: 964.
15. PESCE MA, BODOURIAN SH. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther Drug Monit 1986; 8: 115.
16. NAJJAR TA, MATAR KM, ALFAWAZ IM. Comparison of a new high-performance liquid chromatography method with fluorescence polarization immunoassay for analysis of methotrexate. Ther Drug Monit 1992; 14: 142.
17. RIVAS A, RUEGG CL, ZEITUNG J et al. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J Immunol 1995; 154: 4423.
18. MARBERGER M, ALTWEIN JE, STRAUB E, WULFF SH, HOHENFELLNER R. The Lich-Gregoir antireflux plasty: experiences with 371 children. J Urol 1978; 120: 216.
19. SCHUURMAN HJ, PALLY C, FRINGELI-TANNER M, PAPAGEORGIOU C. Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models. Transplantation 2001; 72: 1776.
20. GENESTIER L, PAILLOT R, FOURNEL S et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998; 102: 322.
21. COSTANZO-NORDIN MR, GRUSK BB, SILVER MA et al. Reversal of recalcitrant cardiac allograft rejection with methotrexate. Circulation 1988; 78: III47.
22. Ross HJ, GULLESTAD L, PAK J et al. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. J Heart Lung Transplant 1997; 16: 179.
23. OLSEN NJ, MURRAY LM. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989; 32: 378.
24. HORNUNG N, STENGAARD-PEDERSEN K, EHRNROOTH E et al. The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells. Clin Exp Rheumatol 2000; 18: 691.
25. ALARCON GS. Methotrexate use in rheumatoid arthritis. A clinician's perspective. Immunopharmacology 2000; 47: 259.
26. CHAO NJ, SCHLEGEL PG. Prevention and treatment of graft-versus-host disease. Ann NY Acad Sci 1995; 770: 130.
27. IERINO FL, KOZLOWSKI T, SIEGEL JB et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439.
28. BUHLER L, BASKER M, ALWAYN IP et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70: 1323.
29. COWAN PJ, AMINIAN A, BARLOW H et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504.
30. Loss M, LORENZ R, APPIAH R et al. Disorders of coagulation unrelated to xenograft rejection following pig-to-cynomolgus kidney transplantation. Transplant Proc 2001; 33: 3867.
31. Xu H, GUNDRY SR, HANCOCK WW et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thor Card Surg 1998; 115: 1342.
32. SHOSKES DA, PARFREY NA, HALLORAN PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
33. BERGERON E, ABOUJAOUDE M, SAINT-LOUIS G et al. Acute tubular necrosis in patients after kidney transplantation: associated factors and impact on functional survival of the graft. Ann Chir 1995; 49: 674.
34. SARWAL MM, CECKA JM, MILLAN MT, SALVATIERRA O JR. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing. Transplantation 2000; 70: 1728.